RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Check the time stamp on this data. Updated AI-Generated Signals for Cvs Health Corporation (CVS) available here: CVS.

On Thursday, CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $55.09 which represents a slight increase of $0.82 or 1.51% from the prior close of $54.27. The stock opened at $54.02 ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

CVS Health has an analyst consensus of Moderate Buy, with a price target consensus of $68.15 ... CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; ...

The fund owned 9,662 shares of the pharmacy operator’s stock after selling ... A number of research analysts have recently ...

CVS Health (NYSE:CVS – Get Free Report) will announce its earnings results before the market opens on Wednesday, November 6th ...